LKB Pyeongsan Unveils Integrated Health Bio Center for Comprehensive Care

Introduction to the LKB Pyeongsan Health Bio Center
LKB Pyeongsan Law Firm has taken a significant step forward by establishing the 'LKB Pyeongsan Health Bio Center.' This initiative aims to offer a comprehensive one-stop platform that allows companies to outsource legal, financial, and research and development (R&D) licensing-related services. The center is designed to streamline the process for businesses operating in the health bio industry, making it easier for them to navigate the complex landscape of regulatory compliance and commercialization.
The Need for the Health Bio Center
The establishment of the Health Bio Center was driven by the government's recent focus on regulatory innovation and the development of a growth ecosystem within the health bio sector. This industry is known for its high-risk, high-reward nature, requiring substantial capital and time before profitability can be achieved. Many promising companies, despite having innovative technologies, have encountered challenges due to complex licensing procedures, patent disputes, and unsuccessful investment attempts. Industry professionals often refer to this period as the "valley of death," highlighting the difficulties faced during the early stages of development.
Core Services Offered by the Health Bio Center
The LKB Pyeongsan Health Bio Center plans to provide essential services tailored to the needs of companies in the health bio sector. These include:
- R&D Support: Assistance with research and development activities to foster innovation.
- GMP Production Support: Guidance on Good Manufacturing Practice standards to ensure product quality.
- Non-Clinical and Clinical Trial Support: Help in navigating the processes required for both non-clinical and clinical trials.
- Licensing and Regulatory Affairs Support: Expertise in obtaining necessary licenses and managing regulatory compliance.
- Investment and Fundraising: Strategies and support for securing funding and investments.
- Media Coverage: Assistance in promoting the company's achievements and innovations through media channels.
These services are designed to help companies focus on their core technological development while the center's expert network addresses the obstacles in the commercialization process.
Expansion Through Merger
The merger between LKB Pyeongsan Law Firm and Pyeongsan Law Firm has significantly expanded the pool of experts specializing in various areas, including the health bio industry, pharmaceuticals, medical devices, manufacturing, finance, distribution, patents, and media. This collaboration enhances the center's ability to provide a wide range of services to its clients.
Leadership and Advisory Board
LKB Pyeongsan held a founding general meeting on the 12th of last month, where Co-Chairpersons Lee Woo-ryong and Kim Su-dong were appointed. Lee Woo-ryong, a former Supreme Court judicial research officer, and Kim Su-dong, a Nexgener Representative and former dean of Ajou University’s Pharmaceutical Clinical Graduate School, bring valuable experience to the board. The advisory board includes notable figures such as Lee Sang-mok, former Vice Minister of Science and ICT; Park Hae-sim, former director of Ajou University Medical Center; and Yang Hyun-joo, former Incheon District Chief Judge.
Vision and Goals
Chairperson Lee Woo-ryong emphasized the importance of having a trustworthy legal and management partner in the health bio journey. He stated that the center would act as a strategic partner, helping domestic companies grow within a safe legal framework and expand globally. Advisor Lee Sang-mok added that the center would support the entire cycle of bio R&D, aiming to provide competitiveness that rivals Chinese and U.S. companies.
Merging Operations
LKB Pyeongsan Law Firm and Pyeongsan Law Firm completed their merger process in July and began full-scale joint operations. This merger marks a significant milestone in the evolution of the Health Bio Center, enhancing its capabilities and resources to better serve the health bio industry.
Comments
Post a Comment